Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Adaptive Medical Technologies was a U.S. healthcare technology company focused on commercializing diabetes technology research originating from the University of Virginia Center for Diabetes Technology. The company appears to have positioned itself as a digital health and medical technology business aimed at making diabetes care more connected and contextualized for patients and industry customers, including device makers and pharmaceutical partners. Publicly available information suggests its offering centered on data-driven diabetes management rather than a traditional therapeutic drug pipeline. The legal entity identified in Virginia business records appears to be inactive, and there is limited current evidence of an operating standalone business under this exact name.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Adaptive Medical Technologies.